Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access, and more biotech news
Darron Cummings/AP
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I’ve decided to paint the walls in one of my rooms a dark brown. I may deeply regret this decision. Please send any painting tips!
